Janssen Signs Onto Yale Data-Sharing Project

Janssen, a unit of Johnson & Johnson, said today it will allow a degree of clinical-trial transparency through the Yale School of Medicine's Open Data Access Project (YODA). YODA will act as an independent panel for the drug maker, with the panel reviewing requests from physicians and investigators for access to anonymized, clinical-trial data from Janssen's R&D programs, including those seeking access to the company's pharmaceutical, consumer and medical- device products. The J&J subsidiary's R&D arm will also handle some data requests itself. So-called "external researchers" should . . .